Design: A randomized, double-blind, placebo-controlled 20-week study with 2-year extension (sponsor unblinded at 20 weeks, participants/investigators at 1 year) in 19 European clinical research centers
The side-effect profile observed in animal and in-vitro studies includes: Injection-site irritation
The most common side effects are gastrointestinal: nausea (30-44%), diarrhea (19-30%), constipation (10-24%), and occasional vomiting (9-24%)
When reviewing the literature, you will find that half-life shapes how often a peptide was administered in a given study design
GLP-1s may not only help people by reducing alcohol intake, but also protect the liver from alcohol metabolism-mediated damage, says one coauthor of that study, Wajahat Mehal, MD, who directs the Yale Fatty Liver Disease Program and the Yale Metabolic Health and Weight Loss Program in New Haven, Connecticut
Mounjaro is not the same as Wegovy or Ozempic